Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Application for mining concession for Laver granted

(BOL) STOCKHOLM, Sept. 2, 2025 /PRNewswire/ -- Boliden's application for a mining concession for the Laver deposit has today been granted by the Swedish Mining Authority. The concession grants the ...

How will the addition of copper, gold, silver, and molybdenum from Laver change Boliden’s commodity exposure compared to its peers and impact its valuation multiples? What is the expected development timeline and capital expenditure required to bring the Laver deposit into operation, and how does that align with Boliden’s current financial guidance? How will the Laver concession affect Boliden’s projected production volumes and cash flow over the next 3‑5 years?
Symbol: BOL
Mining
13 days ago
Read more prnewswire

Metallium Awarded its First SBIR Contract from Department of Defense to Use the Company's Flash Joule Heating Technology for Domestic Gallium Recovery from LED Scrap and other Gallium-Rich Waste Streams

(MTMCF) HOUSTON, Sept. 2, 2025 /PRNewswire/ -- Metallium Ltd. (ASX: MTM; OTCQX: MTMCF), announced that its wholly-owned US subsidiary, Flash Metals USA Inc., has been awarded a Phase I Small Busine...

How does Metallium’s flash joule heating gallium recovery technology compare to competing recycling solutions, and what market share could it capture in the LED and electronics waste sectors? What is the timeline for Phase I completion and potential transition to Phase II or full‑scale production, and how might that timing influence the stock price? How significant is the SBIR contract award in terms of Metallium's near‑term revenue and cash flow outlook?
Symbol: MTMCF
Funding
13 days ago
Read more prnewswire

Outlook Therapeutics Requests Type A Meeting with FDA

(NASDAQ:OTLK) ISELIN, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab fo...

What impact could the outcome of the BLA resubmission have on OTLK's valuation relative to other bevacizumab‑based ophthalmic competitors? How might the FDA's feedback on ONS-5010 affect Outlook Therapeutics' cash runway and need for additional financing? What is the expected timeline for a regulatory decision following the Type A meeting and CRL response?
Symbol: OTLK
Regulation
13 days ago
Read more globenewswire

Nauticus Robotics Announces 1-for-9 Reverse Stock Split

(NASDAQ:KITT) HOUSTON, Sept. 2, 2025 /PRNewswire/ -- Nauticus Robotics, Inc. (NASDAQ: KITT, "Nauticus" or the "Company") today announced that it will proceed with a 1-for-9 reverse stock split ("Re...

Is the reverse split being used as a precursor to any strategic initiatives, such as capital raises, acquisitions, or changes in corporate governance that could influence the stock's valuation? How will the reverse split impact existing shareholders' cost basis, potential tax consequences, and overall ownership percentages? What is the company's rationale for the 1-for-9 reverse split and how is it expected to affect the stock's liquidity and market perception?
Symbol: KITT
Stock split
13 days ago
Read more prnewswire